Adverse events432

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 432

Type	Event	Organ system	Group	Affected	At risk	Events
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Acute Open-label Period)	132	1,244	134
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Stabilization Open-label Period)	14	831	14
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Double-blind Randomized Withdrawal Period)	4	294	5
other	Constipation	Gastrointestinal disorders	Placebo + SSRI (Double-blind Randomized Withdrawal Period)	2	292	2
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Randomized Tapered Discontinuation Period)	0	128	0
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Randomized Abrupt Discontinuation Period)	0	132	0
other	Constipation	Gastrointestinal disorders	Placebo + SSRI (Abrupt Discontinuation Period)	0	267	0
other	Constipation	Gastrointestinal disorders	LY2216684 + SSRI (Nonrandomized Abrupt Discontinuation Period)	0	434	0
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Acute Open-label Period)	80	1,244	81
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Stabilization Open-label Period)	10	831	10
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Double-blind Randomized Withdrawal Period)	3	294	3
other	Dry mouth	Gastrointestinal disorders	Placebo + SSRI (Double-blind Randomized Withdrawal Period)	0	292	0
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Randomized Tapered Discontinuation Period)	0	128	0
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Randomized Abrupt Discontinuation Period)	0	132	0
other	Dry mouth	Gastrointestinal disorders	Placebo + SSRI (Abrupt Discontinuation Period)	0	267	0
other	Dry mouth	Gastrointestinal disorders	LY2216684 + SSRI (Nonrandomized Abrupt Discontinuation Period)	1	434	1
other	Nausea	Gastrointestinal disorders	LY2216684 + SSRI (Acute Open-label Period)	147	1,244	155
other	Nausea	Gastrointestinal disorders	LY2216684 + SSRI (Stabilization Open-label Period)	18	831	21
other	Nausea	Gastrointestinal disorders	LY2216684 + SSRI (Double-blind Randomized Withdrawal Period)	7	294	7
other	Nausea	Gastrointestinal disorders	Placebo + SSRI (Double-blind Randomized Withdrawal Period)	5	292	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01299272/events

API reference For AI assistants

Adverse events432

Sources 3

Read this list from software.